Fund Tracker India by Ishaan Dungarwal
Guide
BALPHARMANSEHealthcarePharmaceuticals & BiotechnologyPharmaceuticals

Mutual fund holdings in Bal Pharma Limited: who holds it and who bought and sold in Oct 2026, with its other institutional holdings, each beside the price.

Bal Pharma Limited

MF holding, % of equity
None held
Oct 2026
FPI holding, % of equity
0.28%▲ +0.13 pp
as of 30 Sep 2026
Fund houses holding
0
0 entered, 0 exited · Oct 2026
Promoter pledge
0.00%■ 0.00 pp
as of 30 Sep 2026
Delivery
59.2%▲ +16.0 pp
5 Oct 2026
MTF book
0 sh■ no change
13 Nov 2026
₹86.40▼ −5.0%

NSE close, 16 Nov 2026

1-year range₹60.42₹114.45

Compare with…

Data as of10 sources, each card shows its own date
MF: Oct 2026 portfolios (monthly), 45 fund houses coveredShares outstanding: NSE equity list, 16 Nov 2026Delivery: NSE security-wise delivery, 5 Oct 2026 · 250 days collectedDeals: NSE deal files, 16 Nov 2026SLBM: NSE, 16 Nov 2026 · 64 days collectedMTF: NSE, 13 Nov 2026 · 63 days collectedFlags: NSE, 16 Nov 2026FPI: Shareholding pattern as of 30 Sep 2026, filed 13 Oct 2026Pledge: Shareholding pattern as of 30 Sep 2026Insider: Trades dated 19 Aug 2026 to 16 Nov 2026 (disclosures collected since 3 May 2026)

Questions about Bal Pharma

from the figures on this page

What is the FII, DII and promoter holding in Bal Pharma?

At the Sep 2026 quarter end (NSE shareholding pattern, change vs Jun 2026): promoters 50.86% (unchanged); FIIs 0.28% (+0.13 pp); individuals up to Rs 2 lakh 23.39% (+0.42 pp).

Mutual funds

What it is. Shares of this company held by mutual funds, taken from the portfolio each fund house publishes for every month end. Some index-only schemes publish only every quarter. "Houses" counts the fund houses holding it in an active scheme.

How to read it. "% of equity" is the shares funds hold divided by all the company's shares. A change between two months compares only the houses with a portfolio in both months. Share counts move when funds add to or cut a holding, or when a split or bonus is applied.

Does not show: Trades inside the month, or why a fund changed its holding.

AMC portfolios, Oct 2026 · 45 fund houses covered

No tracked fund house held BALPHARMA in Oct 2026.

Price

NSE close by day · 12 Nov 2025 to 16 Nov 2026

₹86.40 NSE close, 16 Nov 2026

12 Nov 2025: ₹81.5919 Nov 2025: ₹77.9726 Nov 2025: ₹76.703 Dec 2025: ₹73.7610 Dec 2025: ₹72.0017 Dec 2025: ₹73.7124 Dec 2025: ₹73.341 Jan 2026: ₹73.028 Jan 2026: ₹72.6616 Jan 2026: ₹71.4023 Jan 2026: ₹66.402 Feb 2026: ₹66.929 Feb 2026: ₹70.4116 Feb 2026: ₹76.0323 Feb 2026: ₹77.592 Mar 2026: ₹74.7210 Mar 2026: ₹70.9917 Mar 2026: ₹66.3324 Mar 2026: ₹66.572 Apr 2026: ₹65.4010 Apr 2026: ₹75.9420 Apr 2026: ₹77.6927 Apr 2026: ₹75.425 May 2026: ₹75.5212 May 2026: ₹81.2719 May 2026: ₹78.2926 May 2026: ₹92.323 Jun 2026: ₹88.0710 Jun 2026: ₹86.1517 Jun 2026: ₹87.9724 Jun 2026: ₹84.482 Jul 2026: ₹78.469 Jul 2026: ₹77.8516 Jul 2026: ₹86.7223 Jul 2026: ₹88.3930 Jul 2026: ₹87.906 Aug 2026: ₹86.8913 Aug 2026: ₹88.2420 Aug 2026: ₹86.6627 Aug 2026: ₹85.023 Sep 2026: ₹87.7110 Sep 2026: ₹106.2118 Sep 2026: ₹100.6725 Sep 2026: ₹107.715 Oct 2026: ₹106.7912 Oct 2026: ₹97.7119 Oct 2026: ₹91.6827 Oct 2026: ₹83.043 Nov 2026: ₹81.809 Nov 2026: ₹83.1816 Nov 2026: ₹86.40

₹60.42 to ₹114.45, split or bonus adjusted. Since first held = the close at the end of the first month any tracked fund held it, to the latest close.

Shareholders

Shareholding

What it is. Every listed company reports how its shares are split between promoters and the public, within 21 days of each quarter end (companies on the SME exchanges report every half year). This page groups the public part into foreign investors, Indian institutions and retail.

How to read it. Percentages are of the filing's share base. The change column compares with the previous quarter.

Does not show: Trades between quarters.

as of Sep 2026 · Source: NSE shareholding pattern
Category% of filed sharesChange, pp
Promoter and promoter group50.86%0.00 pp
Foreign portfolio investors (FPI)0.28%+0.13 pp
Resident individuals up to Rs 2 lakh (as the filing defines it)23.39%+0.42 pp

% of the filing's shares (ADR, GDR left out) at Sep 2026; pp change against Jun 2026.

How this is counted

Share of the company's shares as filed in its quarterly shareholding pattern (depository-receipt shares are outside the filing's base, so its mutual fund line can sit above the MF holding elsewhere on this page, which is a % of all equity shares). "of which" lines sit inside Domestic institutions. A dash means the filing has no such line, Other public cannot be worked out from the filed lines, or there is no previous quarter to compare.

No line in this filing, so not shown: Domestic institutions (DII), Mutual funds / UTI, Insurance companies, Banks, Provident and pension funds, Alternative investment funds, Other public (derived).

Quarter by quarter

Mar 2026: Promoter and promoter group 50.86%Jun 2026: Promoter and promoter group 50.86%Sep 2026: Promoter and promoter group 50.86%Mar 2026: Foreign portfolio investors (FPI) 0.14%Jun 2026: Foreign portfolio investors (FPI) 0.15%Sep 2026: Foreign portfolio investors (FPI) 0.28%Mar 2026: Resident individuals up to Rs 2 lakh 23.29%Jun 2026: Resident individuals up to Rs 2 lakh 22.97%Sep 2026: Resident individuals up to Rs 2 lakh 23.39%

History from Mar 2026: 3 quarters. Hover a row for every stored quarter.

Named FPIs at 1% or more

Foreign investors who own 1% or more, from the quarterly shareholding pattern. Shows which large foreign funds are on the register.

What it is. Foreign portfolio investors (FPIs) are overseas investors registered with SEBI. The shareholding pattern names every public holder with 1% or more of the company; this card shows the FPIs among them.

How to read it. Filed once a quarter. "Joined" means named this quarter and not last, which can also mean the holder crossed 1% rather than bought a first share. "Left" can likewise mean it fell below 1%.

Does not show: Holdings below 1%, or trades between quarters.

as of 30 Sep 2026
0.28%▲ +0.13 pp vs 30 Jun 2026

FPI category I + II, % of total shares · 0 named at 1% or more

No FPI held 1% or more of Bal Pharma on 30 Sep 2026.

Shareholding pattern as of 30 Sep 2026, filed 13 Oct 2026

FPI holding vs price

Share of the company held by foreign portfolio investors at each quarter end.

Mar 2026 to Sep 2026
Mar 2026: 0% held by FPIs, price —Jun 2026: 0% held by FPIs, price —Sep 2026: 0% held by FPIs, price —

Promoter pledge

Share of the promoters' stake pledged as loan collateral. A rising number means more of the owners' shares are borrowed against.

What it is. Promoters sometimes borrow money against their shares by pledging them: the lender holds the shares as security. Promoters report a pledge or its release to the exchange within seven working days, and the quarterly shareholding pattern shows the shares pledged or otherwise encumbered.

How to read it. Shown as a share of the promoter holding and of all the company's shares, once a quarter. Compare quarters to see the direction.

Does not show: The size of the loan, or the lender's terms.

as of 30 Sep 2026
0.00%■ 0.00 pp vs 30 Jun 2026

of promoter holding · 0.00% of total shares

Promoters had pledged 0 of their 80.97 lakh shares on 30 Sep 2026.

Shareholding pattern as of 30 Sep 2026

Delivery

Delivery

Share of the day's traded volume taken into demat instead of squared off the same day. A higher share means more of the trading was buying to hold.

What it is. Of all shares traded in a day, the part that was settled by delivery: the buyer receives the shares in their demat account. NSE counts this per client, so the rest is shares a client bought and sold within the same day (intraday).

How to read it. NSE publishes the share for every stock every day. Stocks differ in how much they are traded within the day, so compare a stock with its own past rather than with another stock. A 5-day figure smooths out single-day noise.

Does not show: Who the buyers were, or whether they plan to keep the shares.

5 Oct 2026
59.2%▲ +16.0 pp vs 20-day average

20-day average 43.2% · 32nd percentile of the last year

By month over 59 months (Aug 2021 to Oct 2026), 45.4% of shares traded were delivered; lowest month 19.5% (Apr 2025), highest 75.8% (Mar 2026).

NSE security-wise delivery, 5 Oct 2026 · 250 days collected By day, week and month →

Delivery vs price

Share of each session's traded shares taken into demat. High delivery on a falling price means holders took the shares, not just day traders.

14 Aug to 16 Nov
17 Aug: 69% delivered, close ₹85.0019 Aug: 83% delivered, close ₹84.8221 Aug: 80% delivered, close ₹85.9325 Aug: 72% delivered, close ₹85.2227 Aug: 87% delivered, close ₹85.0231 Aug: 74% delivered, close ₹85.002 Sep: 45% delivered, close ₹85.654 Sep: 84% delivered, close ₹87.738 Sep: 59% delivered, close ₹95.3810 Sep: 39% delivered, close ₹106.2116 Sep: 35% delivered, close ₹101.3318 Sep: 65% delivered, close ₹100.6722 Sep: 44% delivered, close ₹108.1624 Sep: 54% delivered, close ₹105.0228 Sep: 49% delivered, close ₹104.7730 Sep: 61% delivered, close ₹109.535 Oct: 59% delivered, close ₹106.79

F&O and margin

MTF book

Shares bought with money borrowed from brokers. A growing book means more of the buying is on margin.

What it is. Margin Trading Facility lets a broker pay part of the price of shares a client buys. The client pays a margin, and the shares bought are held as security. The MTF book is the shares financed this way across all brokers, with the rupee amount.

How to read it. A rising book means more shares are financed with broker loans; a falling book means loans were repaid or shares sold. "% of equity" puts the count next to the company's total shares. The exchange publishes each day's figure the next day.

Does not show: Which brokers or clients are behind it.

13 Nov 2026
0 sh■ no change vs 12 Nov 2026

63rd percentile of 63 days collected

NSE, 13 Nov 2026 · 63 days collected

MTF book vs price

Shares bought on broker margin, each session. A book that grows while the price falls means more buyers are borrowing to hold.

1 Sep to 16 Nov
1 Sep: 300 shares on margin, close ₹85.452 Sep: 300 shares on margin, close ₹85.653 Sep: none, close ₹87.719 Sep: 5,000 shares on margin, close ₹114.4510 Sep: 13,201 shares on margin, close ₹106.2111 Sep: 13,821 shares on margin, close ₹107.4215 Sep: 13,821 shares on margin, close ₹107.4416 Sep: 13,821 shares on margin, close ₹101.3317 Sep: 13,821 shares on margin, close ₹102.4618 Sep: 13,820 shares on margin, close ₹100.6721 Sep: 13,820 shares on margin, close ₹109.3722 Sep: 13,820 shares on margin, close ₹108.1623 Sep: 13,819 shares on margin, close ₹108.2824 Sep: 13,519 shares on margin, close ₹105.0225 Sep: 13,519 shares on margin, close ₹107.7128 Sep: 13,519 shares on margin, close ₹104.7729 Sep: 18,537 shares on margin, close ₹112.1130 Sep: 18,537 shares on margin, close ₹109.531 Oct: 13,537 shares on margin, close ₹105.745 Oct: 12,337 shares on margin, close ₹106.796 Oct: 2,436 shares on margin, close ₹101.467 Oct: 2,436 shares on margin, close ₹98.628 Oct: 620 shares on margin, close ₹96.219 Oct: 620 shares on margin, close ₹93.0612 Oct: none, close ₹97.71

Red flags

The exchange's own lists: F&O ban and surveillance. They say the stock is on a list, not why it moved.

What it is. Exchange lists that restrict trading in a stock: the F&O ban (no fresh F&O positions), and the Additional and Graded Surveillance Measures (ASM and GSM), which tighten trading conditions with steps such as higher margins, narrower price bands and trade-for-trade settlement.

How to read it. The card shows whether the stock is on a list today, from the exchange's daily files.

Does not show: Anything about the company beyond being listed.

16 Nov 2026
No F&O

Bal Pharma has no F&O contracts in NSE's combined open-interest file, so the F&O ban does not apply. NSE listed Bal Pharma under no ASM or GSM stage on 16 Nov 2026. Pledge invocations are not available yet.

NSE, 16 Nov 2026

Nothing to show for Bal Pharma in the period checked Bulk and block deals: No bulk or block deals in Bal Pharma from 19 Aug 2026 to 16 Nov 2026. · Insider and promoter: No insider or promoter trade in Bal Pharma dated 19 Aug 2026 to 16 Nov 2026 was disclosed. · SLBM borrowing: NSE listed no securities-lending (SLB) open position for Bal Pharma on any of the 64 days collected, 14 Aug 2026 to 16 Nov 2026. No SLBM trades in Bal Pharma on 16 Nov 2026.

Sources

AMC monthly portfolios (SEBI disclosure) · NSE end-of-day close · NSE shareholding pattern filings (XBRL), quarterly · NSE security-wise delivery, daily · NSE bulk and block deals, daily · NSE insider trading disclosures (SEBI PIT, XBRL) · NSE F&O ban list, market-wide position limits and surveillance indicators, daily · NSE margin trading disclosure, daily · NSE securities lending and borrowing (SLBS, SLBM), daily. Each card and table shows its own date.

Report a wrong number

Followed pages